TIRZA (GLP1+GIP) 5mg / 10mg / 20mg
TIRZA – laboratory-grade synthetic research peptide
TIRZA (GLP1+GIP) 5mg / 10mg / 20mg is a research compound intended exclusively for laboratory applications. It is characterized by a high degree of purity and stability under experimental conditions. The preparation offered is not a food, dietary supplement, cosmetic, medicinal product, medical device, or substance intended for use as a medicine or an ingredient in a medicinal product. It is not intended for consumption, administration, or use in humans or animals. It must be used solely for its intended research and laboratory purposes.
Description
TIRZA – GIP/GLP-1 peptide analogue (research standard)
TIRZA is a synthetic incretin peptide that is an analogue of a sequence inspired by the hormones GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). The compound was designed as a ligand that interacts with incretin receptors in experimental models.
Product characteristics
- synthetic peptide acting as a dual receptor ligand
- ability to interact with GIP and GLP-1 receptors under laboratory conditions
- modified structure that increases stability in experimental systems
- suitable for biochemical and molecular research
Applications
The product is intended exclusively for laboratory applications, particularly for:
- research on incretin receptors
- analysis of ligand–receptor interactions
- cellular-level experiments (in vitro)
- research on signalling pathways associated with peptide receptors
- research and development (R&D)
Technical specifications
- Working name: TIRZA
- Type: synthetic peptide
- Form: lyophilized powder
- Purity: ≥ 99%
Safety information
The product is intended exclusively for laboratory use.
It is not intended for use in humans or animals.
It is not a medicinal product, medical device or dietary supplement.
The product is not authorized for marketing as a pharmaceutical substance.
Additional information
| Zawartość | 5 mg, 10 mg, 20 mg |
|---|
